Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes

Part of paid clinical trials in Columbia, Missouri.

Sponsor
University of Missouri-Columbia
Study ID
NCT06571500
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 59 Years
Healthy Volunteers
Accepted

Study Details

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a family history of type 2 diabetes at the University of Missouri. Our aim is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.

Key Dates

First listed
Aug 26, 2024
Start date
Jul 15, 2025
Status verified
Apr 2026
Primary completion
Sep 1, 2028
Completion
Sep 1, 2030

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Men and women with a family history of type 2 diabetes
  • Arm: Men and women without a family history of type 2 diabetes

Primary Outcome Measure

Beta-cell function [ Time Frame: before and 7 days after rhGH administration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Missouri School of MedicineColumbiaMissouri65212
Bettina Mittendorfer
[email protected]
573-882-9377

Find similar trials in Columbia, MO

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Missouri School of Medicine· Columbia, MO

Related Studies